Target Name: OR11G2
NCBI ID: G390439
Review Report on OR11G2 Target / Biomarker Content of Review Report on OR11G2 Target / Biomarker
OR11G2
Other Name(s): OR14-34 | Olfactory receptor 11G2 | Olfactory receptor OR14-34 | olfactory receptor OR14-34 | Olfactory receptor family 11 subfamily G member 2, transcript variant 1 | O11G2_HUMAN | OR11G2 variant 1 | olfactory receptor family 11 subfamily G member 2

OR11G2: A Potential Drug Target for Tissue Survival and Function

OR11G2 (OR14-34) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. Its function is not well understood, but it is known to be involved in several cellular processes that are important for cell survival and function. Based on this information, OR11G2 has been identified as a potential drug target and may be useful for the treatment of several diseases.

One of the functions of OR11G2 is its role in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. OR11G2 is involved in the formation of tight junctions, which are the weakest type of cell-cell adhesion. These tight junctions are critical for the integrity of tissues and organs and are often disrupted in diseases such as cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, targeting OR11G2 with drugs that can modulate its function in cell adhesion could be a promising strategy for the treatment of these diseases.

OR11G2 is also involved in the regulation of cell signaling pathways. Signaling pathways are the processes by which cells communicate with one another to coordinate their activities. OR11G2 is involved in several signaling pathways, including the TGF-β pathway and the Wnt pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. Wnt is a signaling pathway that is involved in the development and maintenance of tissues and organs. OR11G2 is known to be involved in the regulation of TGF-β and Wnt signaling pathways and is thought to play a role in the development and maintenance of tissues and organs. Therefore, targeting OR11G2 with drugs that can modulate its function in these signaling pathways could be another promising strategy for the treatment of diseases such as cancer and neurodegenerative diseases.

OR11G2 is also involved in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body. Apoptosis is a natural process that is important for the development and maintenance of tissues and organs and is regulated by several signaling pathways. OR11G2 is known to be involved in the regulation of apoptosis and is thought to play a role in the maintenance of tissues and organs. Therefore, targeting OR11G2 with drugs that can modulate its function in apoptosis could be another promising strategy for the treatment of diseases such as cancer and neurodegenerative diseases.

In conclusion, OR11G2 is a protein that is involved in several cellular processes that are important for cell survival and function. Based on this information, OR11G2 has been identified as a potential drug target and may be useful for the treatment of several diseases. Further research is needed to fully understand the function of OR11G2 and to develop effective drugs that can target its function.

Protein Name: Olfactory Receptor Family 11 Subfamily G Member 2

Functions: Odorant receptor

The "OR11G2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR11G2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1